Structure and Stereochemistry of the Active Metabolite of Clopidogrel

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)

The Lancet · 1996 · 6.5K citations

Medicine, Pharmacology, Pharmacotherapy +10

Identification and Biological Activity of the Active Metabolite of Clopidogrel

Pierre Savi, Jean‐Marie Pereillo, Marie-Françoise Uzabiaga et al. · Thrombosis and Haemostasis · 2000 · 748 citations

Medicine, Medicinal Chemistry, Pharmacology +17

The Antiaggregating Activity of Clopidogrel Is due to a Metabolic Activation by the Hepatic Cytochrome P450-1A

Pierre Savi, Jean Combalbert, C Gaich et al. · Thrombosis and Haemostasis · 1994 · 283 citations

Medicine, Pharmacology, Pharmacotherapy +17

P2Y12, a New Platelet ADP Receptor, Target of Clopidogrel

Pierre Savi, Catherine Labouret, Nathalie Delesque et al. · Biochemical and Biophysical Research Communications · 2001 · 274 citations

Medicine, Pharmacology, Pharmacotherapy +12

The <i>in vivo</i> pharmacological profile of CS‐747, a novel antiplatelet agent with platelet ADP receptor antagonist properties

Atsuhiro Sugidachi, Fumitoshi Asai, Taketoshi Ogawa et al. · British Journal of Pharmacology · 2000 · 235 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17